Cargando…
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
Preventing SARS-CoV-2 infection by modulating viral host receptors, such as angiotensin-converting enzyme 2 (ACE2)(1), could represent a new chemoprophylactic approach for COVID-19 that complements vaccination(2,3). However, the mechanisms that control the expression of ACE2 remain unclear. Here we...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977684/ https://www.ncbi.nlm.nih.gov/pubmed/36470304 http://dx.doi.org/10.1038/s41586-022-05594-0 |